Literature DB >> 19461836

Opioid induced hyperalgesia: clinical implications for the pain practitioner.

Sanford M Silverman1.   

Abstract

Opioids have been and continue to be used for the treatment of chronic pain. Evidence supports the notion that opioids can be safely administered in patients with chronic pain without the development of addiction or chemical dependency. However, over the past several years, concerns have arisen with respect to administration of opioids for the treatment of chronic pain, particularly non-cancer pain. Many of these involve legal issues with respect to diversion and prescription opioid abuse. Amongst these, opioid induced hyperalgesia (OIH) is becoming more prevalent as the population receiving opioids for chronic pain increases. OIH is a recognized complication of opioid therapy. It is a pro-nocioceptive process which is related to, but different from, tolerance. This focused review will elaborate on the neurobiological mechanisms of OIH as well as summarize the pre-clinical and clinical studies supporting the existence of OIH. In particular, the role of the excitatory neurotransmitter, N-methyl-D-aspartate appears to play a central, but not the only, role in OIH. Other mechanisms of OIH include the role of spinal dynorphins and descending facilitation from the rostral ventromedial medulla. The links between pain, tolerance, and OIH will be discussed with respect to their common neurobiology. Practical considerations for diagnosis and treatment for OIH will be discussed. It is crucial for the pain specialist to differentiate amongst clinically worsening pain, tolerance, and OIH since the treatment of these conditions differ. Tolerance is a necessary condition for OIH but the converse is not necessarily true. Office-based detoxification, reduction of opioid dose, opioid rotation, and the use of specific NMDA receptor antagonists are all viable treatment options for OIH. The role of sublingual buprenorphine appears to be an attractive, simple option for the treatment of OIH and is particularly advantageous for a busy interventional pain practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461836

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  47 in total

Review 1.  Perioperative Hyperalgesia and Associated Clinical Factors.

Authors:  Obaid S Malik; Alan D Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2017-01

Review 2.  Managing difficult pain conditions in the cancer patient.

Authors:  Sebastiano Mercadante
Journal:  Curr Pain Headache Rep       Date:  2014-02

3.  A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide.

Authors:  Angee Baldini; Michael Von Korff; Elizabeth H B Lin
Journal:  Prim Care Companion CNS Disord       Date:  2012-06-14

Review 4.  Obstacles to the Prescription and Use of Opioids.

Authors:  Rachel S Wallwork; Fallon E Chipidza; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2016-02-18

Review 5.  Adverse effects of chronic opioid therapy for chronic musculoskeletal pain.

Authors:  Leslie J Crofford
Journal:  Nat Rev Rheumatol       Date:  2010-04       Impact factor: 20.543

6.  Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.

Authors:  Aswini Kumar Giri; Christopher R Apostol; Yue Wang; Brittany L Forte; Tally M Largent-Milnes; Peg Davis; David Rankin; Gabriella Molnar; Keith M Olson; Frank Porreca; Todd W Vanderah; Victor J Hruby
Journal:  J Med Chem       Date:  2015-10-30       Impact factor: 7.446

7.  Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV.

Authors:  William C Becker; Kirsha Gordon; E Jennifer Edelman; Robert D Kerns; Stephen Crystal; James D Dziura; Lynn E Fiellin; Adam J Gordon; Joseph L Goulet; Amy C Justice; David A Fiellin
Journal:  AIDS Behav       Date:  2016-03

8.  Opioid-Induced Hyperalgesic Priming in Single Nociceptors.

Authors:  Eugen V Khomula; Dionéia Araldi; Ivan J M Bonet; Jon D Levine
Journal:  J Neurosci       Date:  2020-11-17       Impact factor: 6.167

Review 9.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

Review 10.  Management of opioid medications in patients with chronic pain and risk of substance misuse.

Authors:  Seddon R Savage
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.